Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Cancer Vaccines01:30

Cancer Vaccines

867
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
867
Cancer Survival Analysis01:21

Cancer Survival Analysis

573
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
573

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stable Chelation of Zr-89 and Ac-225 with Dual Size-Selective Macrocyclic py<sub>2</sub>-macrodipa for <sup>225</sup>Ac/<sup>89</sup>Zr Paired Theranostics.

Inorganic chemistry·2026
Same author

Exploratory FDG PET/CT Imaging in mCRPC Patients Treated with Sipuleucel-T ± IL-7: A Phase II Trial Subanalysis.

International journal of molecular sciences·2026
Same author

Phosphinate or Urea? Synthesis and Biological Evaluation of Prostate Specific Membrane Antigen-Targeted Fluorophores With Different Zinc-Binding Motif.

ChemMedChem·2026
Same author

A Siderophore-Antibiotic Heterodimer Imaging Agent Enables <i>In Vivo</i> PET Imaging of <i>S. aureus</i> Infections.

Journal of medicinal chemistry·2026
Same author

Zwitterionic Modification of PSMA Ligands Reduces Off-Target Binding and Tissue Retention.

Journal of medicinal chemistry·2026
Same author

Sclerostin deficiency sensitizes white adipocytes to thermogenic signals that induce beiging in mice.

Nature communications·2026

Related Experiment Video

Updated: Dec 17, 2025

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

1.0K

Prostate Cancer Theranostics - An Overview.

Diane Abou1,2,3, Nadia Benabdallah1,2, Wen Jiang2,4

  • 1Department of Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, United States.

Frontiers in Oncology
|June 26, 2020
PubMed
Summary
This summary is machine-generated.

New theranostic approaches offer hope for metastatic prostate cancer by enabling earlier detection and personalized treatment strategies. These molecularly specific tools target cancer cells for diagnosis and therapy.

Keywords:
alpha particlepeptideprostate cancerradionuclideradiotherapy

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.6K
Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

1.0K

Related Experiment Videos

Last Updated: Dec 17, 2025

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

1.0K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.6K
Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

1.0K

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Molecular Imaging

Background:

  • Metastatic prostate cancer remains incurable, necessitating advancements in early detection and targeted treatment.
  • Molecularly specific tools are crucial for localizing diagnostic and therapeutic radionuclide payloads to prostate cancer cells and the tumor microenvironment.
  • Theranostic approaches are emerging as a key strategy for characterizing and personalizing patient management in prostate cancer.

Purpose of the Study:

  • To review clinically translated theranostic approaches for prostate cancer.
  • To summarize methods for detecting, characterizing, and treating prostate cancer using molecularly specific tools.
  • To highlight the expanding field of theranostics in managing prostate cancer.

Main Methods:

  • Literature review of clinically translated theranostic strategies.
  • Analysis of molecularly specific tools for radionuclide payload delivery.
  • Summary of approaches for prostate cancer detection, characterization, and treatment.

Main Results:

  • Theranostic approaches are increasingly being realized for prostate cancer patients.
  • Molecularly specific tools enable precise localization of diagnostic and cytotoxic agents.
  • The field of theranostics for prostate cancer is rapidly expanding with clinically relevant applications.

Conclusions:

  • Clinically translated theranostic approaches are vital for advancing prostate cancer management.
  • Molecularly targeted radionuclide therapies offer a promising avenue for treating metastatic disease.
  • Personalized patient management through theranostics is transforming prostate cancer care.